# A Phase 1 Study of XL019 in Adults With Polycythemia Vera

> **NCT00595829** · PHASE1 · TERMINATED · sponsor: **Exelixis** · enrollment: 3 (actual)

## Conditions studied

- Polycythemia Vera

## Interventions

- **DRUG:** XL019

## Key facts

- **NCT ID:** NCT00595829
- **Lead sponsor:** Exelixis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-12
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2015-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00595829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00595829, "A Phase 1 Study of XL019 in Adults With Polycythemia Vera". Retrieved via MORVS 2026-10-19 from https://api.morvs.ai/clinical/NCT00595829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*